Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for emergence and postoperative sleep quality in elderly spinal surgery
ChiCTR2500110216Phase 4Not yet recruiting
- Sponsor
- The Third Hospital of Hebei Medical University
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in postoperative delirium (POD), confusion, sleep disorders secondary to medical conditions and 2 more (2 arms), sponsored by The Third Hospital of Hebei Medical University. Primary endpoint: Quality of awakening. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)confusionsleep disorders secondary to medical conditionsAnesthesia-related recovery impairment (ARRI)postoperative pain
Beyond the preview
Go deeper on ChiCTR2500110216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110216.